Check the latest share price of Procter & Gamble Health Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
₹5604
as on 04:01PM, 04 Jun 2025
NSE
Get live Procter & Gamble Health Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 14.53 % |
3 Month Return | + 12.73 % |
1 Year Return | + 19.88 % |
3 Year Return | + 31.91 % |
5 Year Return | + 34.52 % |
Market Stats | |
Previous Close | ₹5,749.50 |
Open | ₹5,762.00 |
Volume | 8,155.00 |
Upper Circuit | ₹6,899.00 |
Lower Circuit | ₹4,600.00 |
Check Procter & Gamble Health Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹9,543.81 Cr
Return on Equity (ROE)
31.18
PE Ratio (TTM)
0Return on capital employed (ROCE)
39.76
Beta (LTM)
0.43
P/B Ratio
15.57
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
31.4
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Investing in Procter & Gamble Health Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Procter & Gamble Health Ltd or PGHL on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Procter & Gamble Health Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Procter & Gamble Health Ltd with just a few clicks!
Get share price movements and forecasts by analysts on Procter & Gamble Health Ltd.
Excluding Excise Duty and Other Income, represents Net Revenue
Procter & Gamble Health Ltd revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
Procter & Gamble Health Ltd EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Procter & Gamble Health Ltd, including revenue, profit, loss and more.
Check stock indices that include Procter & Gamble Health Ltd.
View detailed summary of the earnings and dividend history of Procter & Gamble Health Ltd.
Procter & Gamble Health Ltd’s net profit jumped 31.4% since last year same period to ₹61.18Cr in the Q4 2024-2025. On a quarterly growth basis, Procter & Gamble Health Ltd has generated -32.7% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending December 2024, Procter & Gamble Health Ltd has declared dividend of ₹80 - translating a dividend yield of 2.50%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Procter & Gamble Health Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 51.82% | 0.00 | |
Foreign Institutions | 6.87% | 0.00 | |
Mutual Funds | 10.54% | 0.00 | |
Retail Investors | 27.11% | 0.00 | |
Others | 3.67% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Procter & Gamble Health Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 9,543.81 | 6.9% | 0.53 | NA | NA | |
BUY | 25,817.98 | 98.43% | 0.52 | NA | NA | |
BUY | 18,712.97 | 30.38% | 0.57 | NA | NA | |
NA | 6,334.01 | 8.3% | 0.79 | NA | NA | |
BUY | 14,229.42 | 42.25% | 0.68 | NA | NA |
Latest news and events in one place to help you make informed investing decisions in Procter & Gamble Health Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, PGHL stock has moved up by 7.5%
Retail Holding Up
Retail Investor have increased holdings from 26.46% to 27.11% in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.4% return, outperforming this stock by 93.5%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.0% return, outperforming this stock by 31.1%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.82% of holdings in Mar 2025 quarter
MF Holding Down
Mutual Funds have decreased holdings from 10.64% to 10.54% in Mar 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 7.01% to 6.87% in Mar 2025 quarter
Organisation | Procter & Gamble Health Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | S N Talwar |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Procter & Gamble Health Ltd.
Procter & Gamble Health Ltd share price today stands at ₹5604, Open: ₹5762, Previous Close: ₹5749.5, High: ₹5782.5, Low: ₹5585.5, 52 Week High: ₹5944.5, 52 Week Low: ₹4641.15.
Today's traded volume of Procter & Gamble Health Ltd is 8,155.00. Which means that 8,155.00 shares of Procter & Gamble Health Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Procter & Gamble Health Ltd is ₹9,543.81 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Procter & Gamble Health Ltd’s 52 week high is ₹5944.5 and 52 week low is ₹4641.15. The current share price of Procter & Gamble Health Ltd is ₹5604, which is -5.73% down from its 52 week high and 20.75% up from its 52 week low.